Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2
Ependymoma Hub
V1V2
Sign in
← Cases

DCLK3

RBC: DCAMKL3 · Substrate: Ziptide ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Repotrectinib79.00.61
Darovasertib58.40.72
Canertinib17.70.67
Quizartinib16.40.74
Remibrutinib7.60.72
Capivasertib2.10.64
Inavolisib1.50.68

Known variants

No variants catalogued.
Open in new tab